AMA President Urges Rx Makers To Provide Cheap Naloxone

Medicaid health plans and the nation's largest physician lobby group are raising concerns about the rising prices of the opioid overdose treatment naloxone, with American Medical Association President Steven Stack demanding the pharmaceutical industry cast profit interests aside and help solve the nation's public health epidemic by ensuring the product is as “cheap as water.” Stack said that access to naloxone is a social need, and “not a profiteering opportunity for anyone in the United States of America.” If a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.